10-Q Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001558370-21-014670`
Period End Date	20210930
Filing Date	20211104
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	iova-20210930x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 63 Income Statement 40 Cash Flow Statement 59 Stockholders Equity 33 Comprehensive Income 12

Balance Sheet 63 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$67.33M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$68.31M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$58.59M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$517.86M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$562.11M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.58M	USD	Point-in-time
Prepaid expenses and other assets	`PrepaidExpenseAndOtherAssetsCurrent`	$6.66M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$636.10M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$583.03M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$59.16M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$88.03M	USD	Point-in-time
Common stock, par or stated value per share	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$72.42M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$54.76M	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$78.25M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	156.70M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	146.87M	shares	Point-in-time
Restricted cash	`RestrictedCash`	$5.53M	USD	Point-in-time
Restricted cash	`RestrictedCash`	$6.08M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	156.70M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	146.87M	shares	Point-in-time
Restricted cash	`RestrictedCash`	$5.53M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$12.92M	USD	Point-in-time
Long-term assets	`OtherAssetsNoncurrent`	$1.01M	USD	Point-in-time
Total Assets	`Assets`	$828.83M	USD	Point-in-time
Total Assets	`Assets`	$768.46M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$12.18M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$13.51M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$35.07M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$45.97M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$6.28M	USD	Point-in-time
Operating lease liabilities - current	`OperatingLeaseLiabilityCurrent`	$6.62M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$64.77M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$54.87M	USD	Point-in-time
Operating lease liabilities - noncurrent	`OperatingLeaseLiabilityNoncurrent`	$45.38M	USD	Point-in-time
Operating lease liabilities - noncurrent	`OperatingLeaseLiabilityNoncurrent`	$64.73M	USD	Point-in-time
Long-term note payable	`LongTermNotesPayable`	$1.00M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$11.71M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$57.09M	USD	Point-in-time
Total Non-Current Liabilities	`LiabilitiesNoncurrent`	$65.73M	USD	Point-in-time
Total Liabilities	`Liabilities`	$111.96M	USD	Point-in-time
Total Liabilities	`Liabilities`	$130.50M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 156,702,653 and 146,874,917 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$6.00K	USD	Point-in-time
Common stock, $0.000041666 par value; 300,000,000 shares authorized, 156,702,653 and 146,874,917 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively	`CommonStockValue`	$7.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$19.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.49B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.77B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-830.19M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.07B	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$698.33M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$656.50M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$298.97M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$711.84M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$744.41M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$758.31M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$768.46M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$828.83M	USD	Point-in-time

Income Statement 40 line items

Line Item	Tag	Value	Unit	Period
Research and development expenses	`ResearchAndDevelopmentExpense`	$149.28M	USD	3 Qtrs
Research and development expenses	`ResearchAndDevelopmentExpense`	$65.36M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpense`	$43.05M	USD	1 Quarter
Research and development expenses	`ResearchAndDevelopmentExpense`	$183.42M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$59.81M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$15.92M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$44.13M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$20.89M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$243.24M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$193.40M	USD	3 Qtrs
Total costs and expenses	`OperatingExpenses`	$58.97M	USD	1 Quarter
Total costs and expenses	`OperatingExpenses`	$86.24M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-58.97M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-86.24M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-243.24M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-193.40M	USD	3 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$395.00K	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$316.00K	USD	3 Qtrs
Interest income, net	`InvestmentIncomeInterest`	$120.00K	USD	1 Quarter
Interest income, net	`InvestmentIncomeInterest`	$2.22M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-242.92M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-86.12M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-58.57M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-191.18M	USD	3 Qtrs
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-1.41	USD	3 Qtrs
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-0.40	USD	1 Quarter
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-0.55	USD	1 Quarter
Net Loss Per Share of Common Stock, Basic	`EarningsPerShareBasic`	$-1.60	USD	3 Qtrs
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-0.55	USD	1 Quarter
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-0.40	USD	1 Quarter
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-1.41	USD	3 Qtrs
Net Loss Per Share of Common Stock, Diluted	`EarningsPerShareDiluted`	$-1.60	USD	3 Qtrs
Weighted Average Shares of Common Stock Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	152,221.00	shares	3 Qtrs
Weighted Average Shares of Common Stock Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	155,508.00	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	146,492.00	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	135,457.00	shares	3 Qtrs
Weighted Average Shares of Common Stock Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	155,508.00	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	146,492.00	shares	1 Quarter
Weighted Average Shares of Common Stock Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	152,221.00	shares	3 Qtrs
Weighted Average Shares of Common Stock Outstanding, Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	135,457.00	shares	3 Qtrs

Cash Flow Statement 59 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-242.92M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-86.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-58.57M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-191.18M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$50.66M	USD	3 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$30.66M	USD	3 Qtrs
Non-cash lease expense	`NonCashLeaseExpense`	$7.63M	USD	3 Qtrs
Non-cash lease expense	`NonCashLeaseExpense`	$5.00M	USD	3 Qtrs
Accretion (amortization) of discounts and premiums on investments	`AmortizationOfDebtDiscountPremium`	$5.18M	USD	3 Qtrs
Accretion (amortization) of discounts and premiums on investments	`AmortizationOfDebtDiscountPremium`	$359.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$819.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.77M	USD	3 Qtrs
Prepaid expenses, other assets, and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-66.00K	USD	3 Qtrs
Prepaid expenses, other assets, and long-term assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-11.99M	USD	3 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$4.99M	USD	3 Qtrs
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$25.30M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$19.69M	USD	3 Qtrs
Operating lease liabilities	`IncreaseDecreaseInOperatingLeaseLiabilities`	$-593.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-740.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$9.17M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$8.26M	USD	3 Qtrs
Accrued expenses and other liabilities	`IncreaseDecreaseInAccruedLiabilities`	$-2.05M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-142.44M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-174.09M	USD	3 Qtrs
Maturities of investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$358.49M	USD	3 Qtrs
Maturities of investments	`ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities`	$544.45M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$711.64M	USD	3 Qtrs
Purchase of investments	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$583.65M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$23.46M	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$30.01M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-69.21M	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-376.61M	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock units	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$283.00K	USD	3 Qtrs
Proceeds from the issuance of common stock upon exercise of options and employee stock purchase plan	`ProceedsFromStockOptionsExercised`	$30.96M	USD	3 Qtrs
Proceeds from the issuance of common stock upon exercise of options and employee stock purchase plan	`ProceedsFromStockOptionsExercised`	$6.70M	USD	3 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$567.04M	USD	3 Qtrs
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$203.16M	USD	3 Qtrs
Proceeds from the issuance of debt	`ProceedsFromIssuanceOfLongTermDebt`	$1.00M	USD	3 Qtrs
Net cash provided in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$573.46M	USD	3 Qtrs
Net cash provided in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$235.12M	USD	3 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$54.42M	USD	3 Qtrs
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect`	$-8.18M	USD	3 Qtrs
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.85M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.42M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$73.83M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, Beginning of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$64.67M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$72.85M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$19.42M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$73.83M	USD	Point-in-time
Cash, Cash Equivalents, and Restricted Cash, End of Period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$64.67M	USD	Point-in-time
Net unrealized loss on short-term investments	`UnrealizedGainLossOnShortTermInvestments`	$-65.00K	USD	3 Qtrs
Net unrealized loss on short-term investments	`UnrealizedGainLossOnShortTermInvestments`	$-24.00K	USD	3 Qtrs
Acquisitions of property and equipment included in accounts payable and accrued expense	`AcquisitionsOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpense`	$8.06M	USD	3 Qtrs
Acquisitions of property and equipment included in accounts payable and accrued expense	`AcquisitionsOfPropertyAndEquipmentIncludedInAccountsPayableAndAccruedExpense`	$635.00K	USD	3 Qtrs
Conversion of convertible preferred stock to common stock	`ConversionOfStockAmountConverted1`	$1.00K	USD	3 Qtrs
Lease liabilities arising from obtaining right-of-use asset from new leases	`Rightofuseassetobtainedinexchangeforoperatingleaseliabilityfromnewleases`	$4.67M	USD	3 Qtrs
Lease liabilities arising from obtaining right-of-use asset from new leases	`Rightofuseassetobtainedinexchangeforoperatingleaseliabilityfromnewleases`	$17.27M	USD	3 Qtrs
Lease liabilities arising from obtaining right-of-use asset from lease modifications	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityFromLeaseModifications`	$7.80M	USD	3 Qtrs
Lease liabilities arising from obtaining right-of-use asset from lease modifications	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityFromLeaseModifications`	$22.00K	USD	3 Qtrs

Stockholders Equity 33 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance	`StockholdersEquity`	$698.33M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$656.50M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$298.97M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$711.84M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$744.41M	USD	Point-in-time
Beginning Balance	`StockholdersEquity`	$758.31M	USD	Point-in-time
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$30.66M	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$50.66M	USD	3 Qtrs
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.71M	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$19.31M	USD	1 Quarter
Common stock issued upon purchase of employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$970.00K	USD	3 Qtrs
Tax payments related to shares withheld for vested restricted stock units	`AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet`	$-283.00K	USD	3 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$20.77M	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$1.52M	USD	1 Quarter
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$29.99M	USD	3 Qtrs
Common stock issued upon exercise of stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.70M	USD	3 Qtrs
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$203.16M	USD	3 Qtrs
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$43.00K	USD	1 Quarter
Common stock sold in public offering, net of offering costs	`StockIssuedDuringPeriodValueNewIssues`	$567.04M	USD	3 Qtrs
Unrealized loss on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-65.00K	USD	3 Qtrs
Unrealized loss on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-24.00K	USD	3 Qtrs
Unrealized loss on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-162.00K	USD	1 Quarter
Unrealized loss on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-38.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-242.92M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-86.12M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-58.57M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-191.18M	USD	3 Qtrs
Ending Balance	`StockholdersEquity`	$698.33M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$656.50M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$298.97M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$711.84M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$744.41M	USD	Point-in-time
Ending Balance	`StockholdersEquity`	$758.31M	USD	Point-in-time

Comprehensive Income 12 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-242.92M	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-86.12M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-58.57M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-191.18M	USD	3 Qtrs
Unrealized loss on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-65.00K	USD	3 Qtrs
Unrealized loss on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-24.00K	USD	3 Qtrs
Unrealized loss on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-162.00K	USD	1 Quarter
Unrealized loss on short-term investments	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-38.00K	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-58.73M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-242.95M	USD	3 Qtrs
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-86.16M	USD	1 Quarter
Comprehensive Loss	`ComprehensiveIncomeNetOfTax`	$-191.25M	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.